Cargando…
Keeping on the High Quality of Health Care in Greek Inflammatory Bowel Disease Patients in the SARS-CoV-2 Era
Autores principales: | Foteinogiannopoulou, Kalliopi, Orfanoudaki, Eleni, Koutroubakis, Ioannis E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
by the AGA Institute
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7214310/ https://www.ncbi.nlm.nih.gov/pubmed/32407971 http://dx.doi.org/10.1016/j.cgh.2020.04.076 |
Ejemplares similares
-
Recent Advances in the Optimization of Anti-TNF Treatment in Patients with Inflammatory Bowel Disease
por: Orfanoudaki, Eleni, et al.
Publicado: (2023) -
Is there a correlation between infliximab trough levels and the development of adverse events in patients with inflammatory bowel disease?
por: Theodoraki, Eirini, et al.
Publicado: (2021) -
Use of vedolizumab in a patient with chronic and refractory pouchitis
por: Orfanoudaki, Eleni, et al.
Publicado: (2018) -
Solid extraintestinal malignancies in patients with inflammatory bowel disease
por: Mala, Anastasia, et al.
Publicado: (2021) -
Real-World Use and Adverse Events of SARS-CoV-2 Vaccination in Greek Patients with Inflammatory Bowel Disease
por: Orfanoudaki, Eleni, et al.
Publicado: (2022)